Ligand validation:7E6Y

OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate

OLC is a Ligand Of Interest in 7E6Y designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7E6Y_OLC_A_405	14%	68%	0.205	0.817	0.57	0.65	-	-	0	0	64%	1
7E6Y_OLC_A_408	11%	63%	0.154	0.775	0.82	0.62	-	-	0	0	40%	1
7E6Y_OLC_A_407	8%	66%	0.208	0.791	0.76	0.55	-	-	1	0	40%	1
7E6Y_OLC_A_404	2%	67%	0.363	0.71	0.75	0.54	-	-	0	0	56%	1
7E6Y_OLC_A_406	1%	70%	0.332	0.606	0.5	0.67	-	-	5	0	72%	1
7E6Y_OLC_A_403	1%	66%	0.261	0.481	0.98	0.35	2	-	11	0	64%	1
7E6Y_OLC_A_409	1%	76%	0.27	0.463	0.67	0.29	-	-	2	0	36%	1
7E6Y_OLC_A_410	0%	77%	0.386	0.556	0.63	0.29	-	-	0	0	32%	1
7E6Y_OLC_A_402	0%	67%	0.394	0.296	0.53	0.75	-	-	5	0	100%	1
9GO1_OLC_A_401	33%	41%	0.165	0.843	1.05	1.24	1	2	0	0	100%	1
9GO2_OLC_A_708	23%	35%	0.14	0.876	0.91	1.62	-	1	0	0	36%	1
7C86_OLC_A_408	21%	86%	0.166	0.884	0.38	0.35	-	-	0	0	40%	1
7E71_OLC_A_410	18%	92%	0.138	0.848	0.34	0.18	-	-	0	0	32%	1
7E6Z_OLC_A_410	14%	90%	0.155	0.831	0.32	0.28	-	-	0	0	32%	1
9F9J_OLC_A_307	100%	42%	0.034	0.981	1.05	1.18	1	2	0	0	100%	1
7YXA_OLC_A_2505	70%	60%	0.127	0.943	0.67	0.84	-	-	3	0	100%	1
9F9D_OLC_A_308	67%	42%	0.081	0.887	0.96	1.29	1	3	0	0	100%	1
7Z0C_OLC_A_803	63%	52%	0.097	0.892	0.82	1.04	1	2	4	0	100%	1
4N6H_OLC_A_1222	63%	56%	0.117	0.932	0.81	0.87	1	1	0	0	88%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.